Krochak R J, Baker D G
Urology. 1986 May;27(5):389-93. doi: 10.1016/0090-4295(86)90399-7.
Radiation nephritis is both volume and dose related. Clinical experience would indicate that a minimum of one third of the renal volume needs to be excluded from nephrotoxic doses which appears to have a threshold of 2,000 cGy. The site of damage leading to renal failure appears to be the microvasculature ultimately expressed as glomerulosclerosis. How much direct damage to the tubular system contributes to this process is unclear, but undoubtedly the resultant systemic physiologic effects potentiate the expression of damage in the irradiated kidney. The acute syndrome, with all the potential manifestations of renal failure, rarely presents sooner than six months and appears to have no clear prodrome, although it would seem reasonable that a subclinical syndrome consisting of abnormalities detectable by urinalysis may occur. Treatment of radiation-induced nephritis or hypertension is no different from treatment for nephritis from any other cause and should be aggressive with lifelong follow-up. Carcinogenesis is a rare late expression of radiation-induced kidney damage.
放射性肾炎与照射剂量及肾脏受照射体积均相关。临床经验表明,肾毒性剂量需排除至少三分之一的肾实质,肾毒性剂量阈值约为2000 cGy。导致肾衰竭的损伤部位似乎是微血管系统,最终表现为肾小球硬化。目前尚不清楚肾小管系统的直接损伤在此过程中起多大作用,但毫无疑问,由此产生的全身生理效应会加重受照射肾脏的损伤表现。急性放射性肾炎综合征表现为肾衰竭的所有潜在症状,很少在6个月内出现,且似乎没有明显的前驱症状,不过,出现由尿液分析可检测到的异常所组成的亚临床综合征似乎是合理的。放射性肾炎或高血压的治疗与其他原因引起的肾炎治疗并无不同,应积极治疗并进行终身随访。致癌是放射性肾损伤罕见的晚期表现。